SCHEMBL14747110

SCHEMBL14747110

c1ccc(-n2nnnc2C2CCCN2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
TAAR1 Q96RJ0 2/20 0.45
ALDH1A1 P00352 7/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
KMT2A Q03164 2/20 0.41
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
NPSR1 Q6W5P4 3/20 0.41
TACR1 P25103 2/20 0.40
HSD11B1 P28845 1/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 1/20 0.40
CCR6 P51684 1/20 0.40
CACNA1B Q00975 1/20 0.40
APBA1 Q02410 1/20 0.40
TSHR P16473 3/20 0.39
LMNA P02545 1/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNA7 P36544 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5648624 0.77 TAAR1 (0.45) TAAR1SMN1; SMN2KMT2ACHRNB2CHRNA7
SCHEMBL5648622 0.77 TAAR1 (0.45) TAAR1SMN1; SMN2KMT2ACHRNB2CHRNA7
SCHEMBL8886238 0.76 TAAR1 (0.42) L3MBTL1TAAR1SMN1; SMN2KMT2AHPGD
SCHEMBL2859000 0.76 HTT (0.44) HTTL3MBTL1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL20816379 0.75 HTT (0.57) HTTL3MBTL1ALDH1A1SMN1; SMN2KMT2A
Hydrochloric Acid SCHEMBL28829510 0.75 HTT (0.43) HTTL3MBTL1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL25241870 0.72 LMNA (0.43) ALDH1A1KMT2ATSHRLMNA
SCHEMBL28475034 0.71 CYP1A2 (0.41) HTTTAAR1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL5314842 0.71 L3MBTL1 (0.50) L3MBTL1TAAR1CHRNB2CHRNA7CHRNA4
SCHEMBL5334794 0.71 L3MBTL1 (0.43) L3MBTL1TAAR1ALDH1A1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2751119-A1 FUSED BICYCLIC DIAMINE DERIVATIVES AS HIV ATTACHMENT INHIBITORS Bristol-Myers Squibb Company (US) 2014-07-09 EP disclosed
WO-2013033061-A1 FUSED BICYCLIC DIAMINE DERIVATIVES AS HIV ATTACHMENT INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2013-03-07 WO disclosed